| Address: | 660 W Germantown Pike #110, Plymouth Meeting, PA 19462, USA |
|---|---|
| Postal code: | 19462 |
| Phone: | (267) 440-4200 |
| Website: | http://www.inovio.com/ |
| Monday: | 9:00 AM – 5:00 PM |
|---|---|
| Tuesday: | 9:00 AM – 5:00 PM |
| Wednesday: | 9:00 AM – 5:00 PM |
| Thursday: | 9:00 AM – 5:00 PM |
| Friday: | 9:00 AM – 5:00 PM |
| Saturday: | Closed |
| Sunday: | Closed |
There are no reviews yet!
You can review this Business and help others by leaving a comment. If you want to share your thoughts about Inovio Pharmaceuticals, use the form below and your opinion, advice or comment will appear in this space.
Find Inovio Pharmaceuticals' contact information and sign up to receive Inovio news directly to your inbox. Partnering Opportunities: Email: business.development@inovio.com. Clinical Trials: 267-440-4237 Email: clinical.trials@inovio.com.
Inovio Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops active DNA immunotherapies and vaccines to prevent and treat cancers and infectious diseases. Inovio Pharmaceuticals, Inc. was founded in 1979 and is headquartered in Plymouth Meeting, Pennsylvania.
Inovio Pharmaceuticals, formerly Genetronics Biomedical, is a late-stage biotechnology company focusing on the discovery, development, and commercialization of DNA immunotherapies that transform the treatment of cancer and infectious diseases.
Webwww.inovio.com. Phone267-440-4200. Inovio Pharmaceuticals Inc (NASDAQ:INO) released its earnings results on Wednesday, May, 9th. The biopharmaceutical company reported ($0.36) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.14) by $0.22.
Inovio Pharmaceuticals, Inc. company research & investing information. Find executives and the latest company news. Inovio Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops active DNA immunotherapies and vaccines to prevent and treat cancers and infectious...
267-440-4200. www.inovio.com. Industry: Biotechnology. Sector: Healthcare. Inovio Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops active DNA immunotherapies and vaccines in combination with proprietary electroporation delivery devices to...
Inovio is taking immunotherapy to the next level in the fight against cancer and infectious diseases. Partners and collaborators include MedImmune, Regeneron Pharmaceuticals, Genentech, GeneOne Life Science, Plumbline Life Sciences investor.relations@inovio.com. Main Phone: +1 267 440-4200.
Inovio Pharmaceuticals, Inc. is engaged in the development of a new generation of vaccines, called synthetic vaccines, focused on cancers and infectious diseases. The Company's SynCon technology enables the design of universal vaccines capable of providing cross-protection against existing or...
Inovio Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops active DNA immunotherapies and vaccines to prevent and treat cancers and infectious diseases. Inovio Pharmaceuticals, Inc. was founded in 1979 and is headquartered in Plymouth Meeting, Pennsylvania.
Inovio Pharmaceuticals, Inc. engages in the development of active DNA immunotherapies for cancer and infectious diseases. Its portfolio of immune therapies includes SynCon immunotherapies and electroporation delivery systems.